France (FR)

Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial (2022) Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder R, Lurz P, Lobo MD, et al. Journal article SplitBFT: Improving Byzantine Fault Tolerance Safety Using Trusted Compartments (2022) Messadi I, Becker MH, Bleeke K, Jehl L, Mokhtar SB, Kapitza R Conference contribution Sodium and quantitative hydrogen parameter changes in muscle tissue after eccentric exercise and in delayed-onset muscle soreness assessed with magnetic resonance imaging (2022) Höger S, Gast L, Marty B, Hotfiel T, Bickelhaupt S, Uder M, Heiß R, Nagel AM Journal article Proton beam range verification by means of ionoacoustic measurements at clinically relevant doses using a correlation-based evaluation (2022) Schauer J, Wieser HP, Huang Y, Ruser H, Lascaud J, Wuerl M, Chmyrov A, et al. Journal article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Macroscopic and microscopic description of phase transition in cerium isotopes (2022) Alexa P, Abolghasem M, Thiamova G, Bonatsos D, Rodriguez TR, Reinhard PG Journal article Tissue mechanics (2022) Kabla A, Ladoux B, Di Meglio JM Journal article Cells as « Tom Thumbs » of living tissues Les cellules, « Petits Poucets » des tissus vivants (2022) D'alessandro J, Barbier-Chebbah A, Voituriez R, Ladoux B Journal article Megahertz-rate ultrafast X-ray scattering and holographic imaging at the European XFEL (2022) Hagstrom NZ, Schneider M, Kerber N, Yaroslavtsev A, Parra EB, Beg M, Lang M, et al. Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients (pts) with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant chemotherapy (NACT) (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution